GT Biopharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -3,775 | -3,411 | -3,710 |
EBIT | -3,763 | -3,604 | -3,906 |
Net Income | -3,775 | -3,411 | -3,710 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,468 | -2,737 | -3,536 |
Cash | 3,951 | 6,418 | 9,249 |
Basic Shares | 1,897 | 2,234 | 1,711 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -14,364 | 5,979 | -20,965 | -57,477 |
EBIT | -7,597 | -42,222 | -114,992 | |
Net Income | -13,162 | -7,597 | -20,503 | -58,693 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,904 | -8,852 | -15,217 | -15,606 |
Cash | 3,951 | 1,079 | 5,672 | 8,968 |
Basic Shares | 1,897 | 1,347 | 1,062 | 8,651 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.68 |
2024-09-30 | -$1.52 |
2024-06-30 | -$2.16 |
2024-03-31 | -$1.64 |
